Subscribe to our Newsletters !!
Drug quality is defined not only how a drug is man
Eppendorf is launching the new VisioNize® box 2,
The journey and merging of sperm and egg cells is
This year, the Hamburg based life sciences company
Alembic Pharmaceutica
Since it’s an ingredient in so many foods, you h
In a world constantly in motion, Microbioz India r
Tacrolimus capsule is an immunosuppressant and can be employed for preventing organ rejection in certain patients after kidney, liver, or heart transplant.
Glenmark Pharmaceuticals Inc, USA, has been granted final approval by the United States Food and Drug Administration (USFDA) for Tacrolimus Capsules USP in the strengths of 0.5 mg, 1 mg and 5 mg, Glenmark said in a regulatory filing.
Quoting IQVIA sales data for the 12 months ending September 2020, Glenmark said the Prograf Capsules, 0.5 mg, 1 mg and 5 mg marketplace achieved annual sales of about USD 286.8 million.
Glenmark said current portfolio consists of 166 products authorised for distribution in the US marketplace and 45 abbreviated new drug applications are pending approval together with the USFDA.
Shares of Glenmark Pharma were trading at Rs 479 each scrip on the BSEup 0.94 per cent over the previous close. PTI SVK BAL
